glp-1 agonists names America's Poison Centers List of GLP-1 Receptor Agonists

Kidney360 2 , 254262 (2021)

GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy THURSDAY, July 16, 2026 -- Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a higher risk for ischemic optic neuropathy (ION) compared with

Its important to recognize the broader effects and consider that patients may benefit even if they dont lose a significant amount of weight

5 These guidelines align with the American Diabetes Association (ADA) standards of care which also provide strong recommendations based on robust clinical trial data supporting the cardiovascular benefits of GLP-1 RAs, particularly in patients with established cardiovascular disease and chronic kidney disease (CKD)

[DOI] [PubMed] [Google Scholar] 348.Trapp S., Hisadome K

For example, 600 mg of quinine stimulates the secretion of GLP-1 and plasma C-peptide